166 related articles for article (PubMed ID: 29234122)
1. Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.
Wenric S; ElGuendi S; Caberg JH; Bezzaou W; Fasquelle C; Charloteaux B; Karim L; Hennuy B; Frères P; Collignon J; Boukerroucha M; Schroeder H; Olivier F; Jossa V; Jerusalem G; Josse C; Bours V
Sci Rep; 2017 Dec; 7(1):17452. PubMed ID: 29234122
[TBL] [Abstract][Full Text] [Related]
2. Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers.
Latgé G; Poulet C; Bours V; Josse C; Jerusalem G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301303
[TBL] [Abstract][Full Text] [Related]
3. Non-coding Natural Antisense Transcripts: Analysis and Application.
Krappinger JC; Bonstingl L; Pansy K; Sallinger K; Wreglesworth NI; Grinninger L; Deutsch A; El-Heliebi A; Kroneis T; Mcfarlane RJ; Sensen CW; Feichtinger J
J Biotechnol; 2021 Nov; 340():75-101. PubMed ID: 34371054
[TBL] [Abstract][Full Text] [Related]
4. Altered antisense-to-sense transcript ratios in breast cancer.
Maruyama R; Shipitsin M; Choudhury S; Wu Z; Protopopov A; Yao J; Lo PK; Bessarabova M; Ishkin A; Nikolsky Y; Liu XS; Sukumar S; Polyak K
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2820-4. PubMed ID: 21098291
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Transcriptome Analysis of Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Positive Breast Cancers by Ribonucleic Acid Sequencing.
Chen P; Song W; Liu L
Gynecol Obstet Invest; 2018; 83(4):338-348. PubMed ID: 29241203
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.
Guffanti A; Iacono M; Pelucchi P; Kim N; Soldà G; Croft LJ; Taft RJ; Rizzi E; Askarian-Amiri M; Bonnal RJ; Callari M; Mignone F; Pesole G; Bertalot G; Bernardi LR; Albertini A; Lee C; Mattick JS; Zucchi I; De Bellis G
BMC Genomics; 2009 Apr; 10():163. PubMed ID: 19379481
[TBL] [Abstract][Full Text] [Related]
7. nocoRNAc: characterization of non-coding RNAs in prokaryotes.
Herbig A; Nieselt K
BMC Bioinformatics; 2011 Jan; 12():40. PubMed ID: 21281482
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.
Kim SW; Fishilevich E; Arango-Argoty G; Lin Y; Liu G; Li Z; Monaghan AP; Nichols M; John B
PLoS One; 2015; 10(3):e0120296. PubMed ID: 25798919
[TBL] [Abstract][Full Text] [Related]
9. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of smut fungi reveals widespread intergenic transcription and conserved antisense transcript expression.
Donaldson ME; Ostrowski LA; Goulet KM; Saville BJ
BMC Genomics; 2017 May; 18(1):340. PubMed ID: 28464849
[TBL] [Abstract][Full Text] [Related]
11. Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer.
Bellido Molias F; Sim A; Leong KW; An O; Song Y; Ng VHE; Lim MWJ; Ying C; Teo JXJ; Göke J; Chen L
Cancer Res; 2021 Dec; 81(23):5849-5861. PubMed ID: 34649947
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
13. The non-coding landscape of head and neck squamous cell carcinoma.
Zou AE; Zheng H; Saad MA; Rahimy M; Ku J; Kuo SZ; Honda TK; Wang-Rodriguez J; Xuan Y; Korrapati A; Yu V; Singh P; Grandis JR; King CC; Lippman SM; Wang XQ; Hinton A; Ongkeko WM
Oncotarget; 2016 Aug; 7(32):51211-51222. PubMed ID: 27323410
[TBL] [Abstract][Full Text] [Related]
14. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
[TBL] [Abstract][Full Text] [Related]
15. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of alternative transcripts in human breast cancer.
Wen J; Toomer KH; Chen Z; Cai X
Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
[TBL] [Abstract][Full Text] [Related]
17. Antisense lncRNA
Širvinskas D; Steponaitis G; Stakaitis R; Tamašauskas A; Vaitkienė P; Skiriutė D
Front Mol Biosci; 2023; 10():1101953. PubMed ID: 36950523
[No Abstract] [Full Text] [Related]
18. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
Bong PN; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Emran NA; Syed Hussain SN
Malays J Pathol; 2010 Dec; 32(2):117-22. PubMed ID: 21329183
[TBL] [Abstract][Full Text] [Related]
19. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.
Wani G; Noyes I; Milo GE; D'Ambrosio SM
Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589
[TBL] [Abstract][Full Text] [Related]
20. Long antisense non-coding RNAs and their role in transcription and oncogenesis.
Morris KV; Vogt PK
Cell Cycle; 2010 Jul; 9(13):2544-7. PubMed ID: 20581457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
